Find Clinical Trials | Cedars-Sinai

153 results found

✔ Specialty: Cancer

Leukemia, other

Inotuzumab Ozogamicin in Children and Young Adults With Relapsed or Refractory CD22+ B-Acute Lymphoblastic Leukemia

This study focuses on children and young adults who have been diagnosed with B-acute lymphoblastic leukemia (B-ALL) that is either unresponsive to therapy (refractory) or has come back after treatment (relapsed). B-ALL is a cancer ...

Lung

Atezolizumab in Early Stage Non-Small Cell Lung Cancer

This study focuses on individuals who have inoperable, early stage non-small cell lung cancer. The purpose of the study is to compare the usual treatment alone to using an immunotherapy drug called atezolizumab plus the ...

Anus, Breast, Colon, Other Female Genital, Ovary, Pancreas, Rectum, Stomach

Human Monoclonal Antibody 5B1 With Expansion in Pancreatic Cancer or Other CA19-9 Positive Malignancies

This study focuses on individuals who have cancer that has tested positive for CA19-9, an antigen (substance that causes an immune response) expressed from pancreatic and other types of cancer. The purpose of the study ...

Breast, Cervix, Colon, Corpus Uteri, Esophagus, Kidney, Liver, Lung, Melanoma ...

KZR-261 in Advanced Solid Malignancies

The purpose of this study is to evaluate the safety and tolerability of an investigational drug called KZR-261 when given via intravenous (IV) infusion for advanced solid tumor cancer. In Part 1 of the study, ...

Melanoma

Subcutaneous Nivolumab and Relatlimab Versus Intravenous Nivolumab and Relatlimab in Previously Untreated Metastatic or Unresectable Melanoma

This study focuses on individuals with previously untreated metastatic or unresectable melanoma (melanoma that has spread or cannot be removed with surgery). A combination of 2 drugs, nivolumab and relatlimab, will be given to participants. ...